tiprankstipranks
Trending News
More News >
Promising Clinical Trial Results and Future Prospects Justify Buy Rating for Kura Oncology
PremiumRatingsPromising Clinical Trial Results and Future Prospects Justify Buy Rating for Kura Oncology
20d ago
Kura Oncology, Kyowa Kirin provide clinical data from KOMET-007
Premium
The Fly
Kura Oncology, Kyowa Kirin provide clinical data from KOMET-007
21d ago
Kura Oncology Stockholders Approve Equity Plan Amendment
Premium
Company Announcements
Kura Oncology Stockholders Approve Equity Plan Amendment
26d ago
Kura Oncology’s FDA Priority Review for Ziftomenib
PremiumCompany AnnouncementsKura Oncology’s FDA Priority Review for Ziftomenib
30d ago
Kura Oncology says ‘positive’ results from KOMET-001 Phase 2 trial of ziftomenib
Premium
The Fly
Kura Oncology says ‘positive’ results from KOMET-001 Phase 2 trial of ziftomenib
1M ago
Kura Oncology’s Ziftomenib Gains FDA Priority Review, Promising Commercial Success in AML Treatment
Premium
Ratings
Kura Oncology’s Ziftomenib Gains FDA Priority Review, Promising Commercial Success in AML Treatment
1M ago
Kura Oncology: Promising Clinical Trials and Stable Financials Justify Buy Rating
PremiumRatingsKura Oncology: Promising Clinical Trials and Stable Financials Justify Buy Rating
2M ago
Kura, Kyowa say ziftomenib abstract accepted for EHA Congress
Premium
The Fly
Kura, Kyowa say ziftomenib abstract accepted for EHA Congress
2M ago
Kura Oncology’s Promising Market Position and Growth Prospects Justify Buy Rating
Premium
Ratings
Kura Oncology’s Promising Market Position and Growth Prospects Justify Buy Rating
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100